Comment on “Major adverse cardiac and cerebrovascular events (MACCEs) in patients with acute ST-segment elevation myocardial infarction (STEMI) treated with pharmaco-invasive strategy of half-dose recombinant human prourokinase (PHDP): Two-year outcomes”
Saved in:
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-02-01
|
| Series: | Asian Journal of Surgery |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S1015958424017822 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832582254995439616 |
|---|---|
| author | Bo Shang |
| author_facet | Bo Shang |
| author_sort | Bo Shang |
| collection | DOAJ |
| format | Article |
| id | doaj-art-ab40e97b3686425bb47e96bf058fe8d5 |
| institution | Kabale University |
| issn | 1015-9584 |
| language | English |
| publishDate | 2025-02-01 |
| publisher | Elsevier |
| record_format | Article |
| series | Asian Journal of Surgery |
| spelling | doaj-art-ab40e97b3686425bb47e96bf058fe8d52025-01-30T05:12:57ZengElsevierAsian Journal of Surgery1015-95842025-02-0148211481149Comment on “Major adverse cardiac and cerebrovascular events (MACCEs) in patients with acute ST-segment elevation myocardial infarction (STEMI) treated with pharmaco-invasive strategy of half-dose recombinant human prourokinase (PHDP): Two-year outcomes”Bo Shang0Corresponding author.; Gansu Provincial Maternity and Child-care Hospital (Gansu Provincial Central Hospital), Lanzhou City, People's Republic of Chinahttp://www.sciencedirect.com/science/article/pii/S1015958424017822Recombinant human prourokinasePrimary percutaneous coronary interventionAcute ST-Segment elevation myocardial infarctionMajor adverse cardiovascular and cerebrovascular eventsFollow up |
| spellingShingle | Bo Shang Comment on “Major adverse cardiac and cerebrovascular events (MACCEs) in patients with acute ST-segment elevation myocardial infarction (STEMI) treated with pharmaco-invasive strategy of half-dose recombinant human prourokinase (PHDP): Two-year outcomes” Asian Journal of Surgery Recombinant human prourokinase Primary percutaneous coronary intervention Acute ST-Segment elevation myocardial infarction Major adverse cardiovascular and cerebrovascular events Follow up |
| title | Comment on “Major adverse cardiac and cerebrovascular events (MACCEs) in patients with acute ST-segment elevation myocardial infarction (STEMI) treated with pharmaco-invasive strategy of half-dose recombinant human prourokinase (PHDP): Two-year outcomes” |
| title_full | Comment on “Major adverse cardiac and cerebrovascular events (MACCEs) in patients with acute ST-segment elevation myocardial infarction (STEMI) treated with pharmaco-invasive strategy of half-dose recombinant human prourokinase (PHDP): Two-year outcomes” |
| title_fullStr | Comment on “Major adverse cardiac and cerebrovascular events (MACCEs) in patients with acute ST-segment elevation myocardial infarction (STEMI) treated with pharmaco-invasive strategy of half-dose recombinant human prourokinase (PHDP): Two-year outcomes” |
| title_full_unstemmed | Comment on “Major adverse cardiac and cerebrovascular events (MACCEs) in patients with acute ST-segment elevation myocardial infarction (STEMI) treated with pharmaco-invasive strategy of half-dose recombinant human prourokinase (PHDP): Two-year outcomes” |
| title_short | Comment on “Major adverse cardiac and cerebrovascular events (MACCEs) in patients with acute ST-segment elevation myocardial infarction (STEMI) treated with pharmaco-invasive strategy of half-dose recombinant human prourokinase (PHDP): Two-year outcomes” |
| title_sort | comment on major adverse cardiac and cerebrovascular events macces in patients with acute st segment elevation myocardial infarction stemi treated with pharmaco invasive strategy of half dose recombinant human prourokinase phdp two year outcomes |
| topic | Recombinant human prourokinase Primary percutaneous coronary intervention Acute ST-Segment elevation myocardial infarction Major adverse cardiovascular and cerebrovascular events Follow up |
| url | http://www.sciencedirect.com/science/article/pii/S1015958424017822 |
| work_keys_str_mv | AT boshang commentonmajoradversecardiacandcerebrovasculareventsmaccesinpatientswithacutestsegmentelevationmyocardialinfarctionstemitreatedwithpharmacoinvasivestrategyofhalfdoserecombinanthumanprourokinasephdptwoyearoutcomes |